These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 37883579)
1. Injectable Zwitterionic Physical Hydrogel with Enhanced Chemodynamic Therapy and Tumor Microenvironment Remodeling Properties for Synergistic Anticancer Therapy. Fang Y; Huang S; Hu Q; Zhang J; King JA; Wang Y; Wei Z; Lu J; He Z; Kong X; Yang X; Ji J; Li J; Zhai G; Ye L ACS Nano; 2023 Dec; 17(24):24883-24900. PubMed ID: 37883579 [TBL] [Abstract][Full Text] [Related]
2. Zwitterionic Injectable Hydrogel-Combined Chemo- and Immunotherapy Medicated by Monomolecular Micelles to Effectively Prevent the Recurrence of Tumor Post Operation. Wang R; Hu Q; Huang S; Fang Y; Kong X; Kaur P; Zhang J; Wang Y; Liu D; Wu H; Li Y; Ji J; Yang X; Ye L; Zhai G ACS Appl Mater Interfaces; 2024 Jan; 16(3):4071-4088. PubMed ID: 38194589 [TBL] [Abstract][Full Text] [Related]
3. Injectable Therapeutic Hydrogel with H Hu P; Jia Z; Zhao S; Lin K; Yang G; Guo W; Yu S; Cheng J; Du G; Shi J Adv Healthc Mater; 2024 Oct; 13(26):e2401551. PubMed ID: 38923861 [TBL] [Abstract][Full Text] [Related]
4. Long-Acting Nanohybrid Hydrogel Induces Persistent Immunogenic Chemotherapy for Suppressing Postoperative Tumor Recurrence and Metastasis. Li Y; Zhu J; Yang Y; Chen Y; Liu L; Tao J; Chen H; Deng Y Mol Pharm; 2023 Dec; 20(12):6345-6357. PubMed ID: 37942616 [TBL] [Abstract][Full Text] [Related]
5. In situ gel implant for postsurgical wound management and extended chemoimmunotherapy against breast cancer recurrence. Wang M; Wang S; Pan Y; Yu R; Zhang ZR; Fu Y Acta Biomater; 2022 Jan; 138():168-181. PubMed ID: 34755605 [TBL] [Abstract][Full Text] [Related]
6. Co-delivery of doxorubicin and STING agonist cGAMP for enhanced antitumor immunity. Xie Y; Li K; Liang J; Wang K; Gong Z; Chen X Int J Pharm; 2024 Apr; 654():123955. PubMed ID: 38423155 [TBL] [Abstract][Full Text] [Related]
7. Implantable 3D Printed Hydrogel Scaffolds Loading Copper-Doxorubicin Complexes for Postoperative Chemo/Chemodynamic Therapy. Dang W; Wang Y; Chen WC; Ju E; Mintz RL; Teng Y; Zhu L; Wang K; Lv S; Chan HF; Tao Y; Li M ACS Appl Mater Interfaces; 2023 Feb; 15(4):4911-4923. PubMed ID: 36656977 [TBL] [Abstract][Full Text] [Related]
8. A homologous-targeting cGAS-STING agonist multimodally activates dendritic cells for enhanced cancer immunotherapy. Wang P; Wang Y; Li H; Wang M; Wang Y; Wang X; Ran L; Xin H; Ma J; Tian G; Gao W; Zhang G Acta Biomater; 2024 Mar; 177():400-413. PubMed ID: 38336268 [TBL] [Abstract][Full Text] [Related]
9. H Tang Z; Jiang S; Tang W; He Q; Wei H; Jin C; Wang S; Zhang H Mol Pharm; 2023 Mar; 20(3):1717-1728. PubMed ID: 36809003 [TBL] [Abstract][Full Text] [Related]
10. Robust and Sustained STING Pathway Activation via Hydrogel-Based In Situ Vaccination for Cancer Immunotherapy. Cheng SL; Lee HM; Li CP; Lin MW; Chou MY; Yen YT; Wu TH; Lian YC; Shih YC; Chiang CS; Chen TW; Wan D; Chen Y ACS Nano; 2024 Oct; 18(43):29439-29456. PubMed ID: 39405469 [TBL] [Abstract][Full Text] [Related]
11. Dendrimer/metal-phenolic nanocomplexes encapsulating CuO Huang H; Guo H; Liu J; Ni C; Xia L; Cao X; Xia J; Shi X; Guo R Acta Biomater; 2024 Jul; 183():252-263. PubMed ID: 38801869 [TBL] [Abstract][Full Text] [Related]
12. A manganese-phenolic network platform amplifying STING activation to potentiate MRI guided cancer chemo-/chemodynamic/immune therapy. Pang X; Fu C; Chen J; Su M; Wei R; Wang Y; Lin W; Wei X; Jiang X; Yang X; Yang H; Wang J; Yang R Biomater Sci; 2023 May; 11(11):3840-3850. PubMed ID: 37074080 [TBL] [Abstract][Full Text] [Related]
14. Huang S; Zhou C; Song C; Zhu X; Miao M; Li C; Duan S; Hu Y Asian J Pharm Sci; 2024 Apr; 19(2):100901. PubMed ID: 38645467 [TBL] [Abstract][Full Text] [Related]
15. An injectable PC Yang J; Wang XJ; Li SM; Jiang DX; Liu YX; Huang Y; Dong DD; Hu W; Liu B J Biomater Sci Polym Ed; 2024 Feb; 35(2):190-205. PubMed ID: 37851402 [TBL] [Abstract][Full Text] [Related]
16. Drug-loaded implantable surgical cavity-adaptive hydrogels for prevention of local tumor recurrence. Zhuang B; Chen T; Xiao Z; Jin Y Int J Pharm; 2020 Mar; 577():119048. PubMed ID: 31978462 [TBL] [Abstract][Full Text] [Related]
17. Tumor phagocytosis-driven STING activation invigorates antitumor immunity and reprograms the tumor micro-environment. Lee S; Hong KH; Park H; Ha J; Lee SE; Park DJ; Jeong SD; Kim S; Kim D; Ahn J; Lee HW; Koh WG; Ha SJ; Kim YC J Control Release; 2024 Sep; 373():55-69. PubMed ID: 38971428 [TBL] [Abstract][Full Text] [Related]
18. Injectable Magnetic Hydrogel Filler for Synergistic Bone Tumor Hyperthermia Chemotherapy. Hu P; Lu J; Li C; He Z; Wang X; Pan Y; Zhao L ACS Appl Bio Mater; 2024 Mar; 7(3):1569-1578. PubMed ID: 38349029 [TBL] [Abstract][Full Text] [Related]
19. Tumor-derived nanovesicles enhance cancer synergistic chemo-immunotherapy by promoting cGAS/STING pathway activation and immunogenetic cell death. Guo Y; Qian R; Li Z; Lv T; Yang C; Li W; Pan T; Hou X; Wang Z Life Sci; 2024 Jul; 348():122687. PubMed ID: 38718856 [TBL] [Abstract][Full Text] [Related]
20. Aptamer-conjugated nano-liposome for immunogenic chemotherapy with reversal of immunosuppression. Kim M; Lee JS; Kim W; Lee JH; Jun BH; Kim KS; Kim DE J Control Release; 2022 Aug; 348():893-910. PubMed ID: 35760233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]